Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P S Sarin

Showing results (51-60 of 117) with videos related to

Pageof 12
Sort By:
Cancer Research|October 1, 1984
Constitutive production and release of a lymphokine with macrophage-activating factor activity distinct from gamma-interferon by a human T-cell leukemia virus-positive cell lineE S Kleinerman, R Zicht, P S Sarin, et al.
Lancet (London, England)|December 21, 1985
In-vitro inhibition of LAV/HTLV-III infected lymphocytes by dithiocarb and inosine pranobexA Pompidou, D Zagury, R C Gallo, et al.
The New England Journal of Medicine|November 14, 1985
Effects of a novel compound (AL 721) on HTLV-III infectivity in vitroP S Sarin, R C Gallo, D I Scheer, et al.
Biochemical Pharmacology|November 15, 1985
Inhibition of HTLV-III/LAV replication by foscarnetP S Sarin, Y Taguchi, D Sun, et al.
Johns Hopkins Medical Journal. Supplement|January 1, 1973
Biochemical properties of reverse transcriptase activities from human cells and RNA tumor virusesR C Gallo, P S Sarin, M G Sarngadharan, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1988
Inhibition of human immunodeficiency virus replication by antisense oligodeoxynucleotidesJ Goodchild, S Agrawal, M P Civeira, et al.
Science (New York, N.Y.)|May 19, 1972
Viral and cellular DNA polymerase: comparison of activities with synthetic and natural RNA templatesM S Robert, R G Smith, R C Gallo, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 1, 1988
Inhibition of acquired immunodeficiency syndrome virus by oligodeoxynucleoside methylphosphonatesP S Sarin, S Agrawal, M P Civeira, et al.
Science (New York, N.Y.)|May 30, 1986
Neutralization of HTLV-III/LAV replication by antiserum to thymosin alpha 1P S Sarin, D K Sun, A H Thornton, et al.
Journal of the National Cancer Institute|October 1, 1984
Karyotypic differences between primary cultures and cell lines from tumors with the human T-cell leukemia virusP C Nowell, J B Finan, J W Clark, et al.
Pageof 12

Showing results (51-60 of 117) with videos related to

Sort By:
Pageof 12
Cancer Research|October 1, 1984
Constitutive production and release of a lymphokine with macrophage-activating factor activity distinct from gamma-interferon by a human T-cell leukemia virus-positive cell lineE S Kleinerman, R Zicht, P S Sarin, et al.
Lancet (London, England)|December 21, 1985
In-vitro inhibition of LAV/HTLV-III infected lymphocytes by dithiocarb and inosine pranobexA Pompidou, D Zagury, R C Gallo, et al.
The New England Journal of Medicine|November 14, 1985
Effects of a novel compound (AL 721) on HTLV-III infectivity in vitroP S Sarin, R C Gallo, D I Scheer, et al.
Biochemical Pharmacology|November 15, 1985
Inhibition of HTLV-III/LAV replication by foscarnetP S Sarin, Y Taguchi, D Sun, et al.
Johns Hopkins Medical Journal. Supplement|January 1, 1973
Biochemical properties of reverse transcriptase activities from human cells and RNA tumor virusesR C Gallo, P S Sarin, M G Sarngadharan, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1988
Inhibition of human immunodeficiency virus replication by antisense oligodeoxynucleotidesJ Goodchild, S Agrawal, M P Civeira, et al.
Science (New York, N.Y.)|May 19, 1972
Viral and cellular DNA polymerase: comparison of activities with synthetic and natural RNA templatesM S Robert, R G Smith, R C Gallo, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 1, 1988
Inhibition of acquired immunodeficiency syndrome virus by oligodeoxynucleoside methylphosphonatesP S Sarin, S Agrawal, M P Civeira, et al.
Science (New York, N.Y.)|May 30, 1986
Neutralization of HTLV-III/LAV replication by antiserum to thymosin alpha 1P S Sarin, D K Sun, A H Thornton, et al.
Journal of the National Cancer Institute|October 1, 1984
Karyotypic differences between primary cultures and cell lines from tumors with the human T-cell leukemia virusP C Nowell, J B Finan, J W Clark, et al.
Pageof 12